Neoral and Injection site papule - a phase IV clinical study of FDA data

Summary:

Injection site papule is reported as a side effect among people who take Neoral (cyclosporine), especially for people who are male, 40-49 old, also take Enbrel,.

The phase IV clinical study analyzes which people have Injection site papule when taking Neoral. It is created by eHealthMe based on reports of 25,970 people who have side effects when taking Neoral from the FDA, and is updated regularly.

What is Neoral?

Neoral has active ingredients of cyclosporine. It is often used in psoriasis. eHealthMe is studying from 26,084 Neoral users. Check the latest studies of Neoral.

What is Injection site papule?

Injection site papule (solid pimple or swelling at injection site) is found to be associated with 198 drugs and 341 conditions by eHealthMe. Check the latest studies of Injection site papule.



On Jul, 10, 2026

25,970 people reported to have side effects when taking Neoral.
Among them, 38 people (0.15%) have Injection site papule.

Could Neoral cause Injection site papule?

Among these 38 people:

What is the gender of people who have Injection site papule when taking Neoral? *

  • female: 0.0 %
  • male: 100 %

What is the age of people who have Injection site papule when taking Neoral? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Neoral? *

  1. Soriatane: 38 people, 100.00%
  2. Remicade: 38 people, 100.00%
  3. Humira: 38 people, 100.00%
  4. Enbrel: 38 people, 100.00%
  5. Stelara: 37 people, 97.37%
  6. Cosentyx: 32 people, 84.21%

What are other side effects people have besides Injection site papule? *

  1. Weakness: 38 people, 100.00%
  2. Venous Injury: 38 people, 100.00%
  3. Pain In Extremity: 38 people, 100.00%
  4. Nausea (feeling of having an urge to vomit): 38 people, 100.00%
  5. Muscle Aches (muscle pain): 38 people, 100.00%
  6. Insomnia (sleeplessness): 38 people, 100.00%
  7. Injection Site Haemorrhage (bleeding from injection site): 38 people, 100.00%
  8. Headache (pain in head): 38 people, 100.00%
  9. Drug Ineffective: 38 people, 100.00%
  10. Injection Site Swelling: 34 people, 89.47%

* Approximation only. Some reports may have incomplete information.

Do you take Neoral and have Injection site papule?

- Check whether Injection site papule is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neoral:

Injection site papule treatments and more:

How severe was Injection site papule and when was it recovered:

Expand to all the drugs that have ingredients of cyclosporine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neoral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site papule:

Browse all the conditions that are associated with Injection site papule:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Neoral) and Neoral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: